• 제목/요약/키워드: Drug policy

검색결과 364건 처리시간 0.027초

Development of Hazardous Materials Management Standard for Decoction Type of Personalized Herbal Medicine

  • Jeong, Hye-In;Kim, Kyeong-Han;Won, Jae-Hee;Sung, Gi-Un;Kim, Ji-Won;Han, Ji-eun;Sung, Angela Dong-Min;Park, Eun-Jung;Sung, Soo-Hyun
    • 대한약침학회지
    • /
    • 제23권2호
    • /
    • pp.71-78
    • /
    • 2020
  • Objectives: This study was conducted to development of hazardous materials management standards for the decoction type of personalized herbal medicines (PHMs). Methods: This study was conducted in two stages. We searched documents about criteria to use words such as 'Herb', 'Herbal medicine', and 'Botanical Drug' and summarized the results. We organized the committee consisted of seven experts, and held two meetings to reach an agreement on hazardous management standards of the decoction type of PHMs. Results: The seven documents were presented in the literature review and six items related to hazardous management standards of decoction were identified. The second expert meeting brought that a total of six items, including heavy metal, pesticide residues, sulfur dioxide, benzopyrene, mycotoxin, and micro-organism limits, were selected for safety management of decoction type of PHMs. Also, the criteria and test methods for each standard were suggested for monitoring the decoction type of PHMs. Conclusion: The study suggested hazardous material management standards and criteria for the decoction types of PHMs. In the future, it would be necessary to conduct a pilot test to ensure the validity and credibility of the safety management standard and criteria. Furthermore, the government level safety management system should be introduced to verify the safety of decoction medicines.

LC-MS/MS를 이용한 돼지고기 중 총아플라톡신 및 오크라톡신 A 동시분석법 확립 (Simultaneous Determination of Aflatoxins and Ochratoxin A in Pork by LC-MS/MS)

  • 백옥진;박송이;박기훈;김신희;서세정;윤혜정
    • 한국식품위생안전성학회지
    • /
    • 제31권3호
    • /
    • pp.194-200
    • /
    • 2016
  • 돼지고기 중 5종의 곰팡이독소(아플라톡신 $B_1$, $B_2$, $G_1$, $G_2$ 및 오크라톡신 A)를 분석하기 위해 0.1% 개미산을 함유한 50% 아세토니트릴용액으로 추출한 후 고체상추출칼럼을 이용하여 정제하고, LC-MS/MS로 동시 정량할 수 있는 시험법을 마련하였다. 분석조건으로 측정한 5종의 곰팡이독소 matrix-matched 표준곡선식에서 모두 상관계수 0.998이상의 상관관계를 나타내었다. 5종의 곰팡이독소 2배의 정량한계에서 10배의 정량한계로 첨가한 시료에서 평균 회수율은 72.1~109.9%로 실험 결과들이 EU 가이드라인에서 제시하는 유효성 확인을 위한 기준을 만족함으로써 시험법의 신뢰성을 확보할 수 있었다. 충청지역 유통되고 있은 돼지고기 20건에 대한 총아플라톡신 및 오크라톡신A에 대한 오염도 조사결과 정량한계 미만으로 조사되었다.

미국 및 유럽 의료기기 품목분류 체계 분석을 통한 국내 의료기기 품목분류 개선 연구 (A Study on the Improvement of Domestic Medical Device Product Classification through Analysis of Medical Device Classification System in the U.S. and Europe)

  • 유강현;손지민;권경민;김유림;이희성;장원석
    • 대한의용생체공학회:의공학회지
    • /
    • 제44권1호
    • /
    • pp.73-79
    • /
    • 2023
  • The purpose of this study is to derive medical devices with different management systems through comparison of domestic and overseas medical device product classification systems and to propose management conversion measures for the products. The definitions of medical devices were compared and the scope of medical devices defined by each country was confirmed through surveys of the Medical Device Act, Federal Food, Drug & Cosmetics Act (FD&C) in the U.S., and Medical Device Regulations (MDR) in Europe. Using the Ministry of Food and Drug Safety's regulations on medical device products and grades, 21 CFR part 860-892 and product code classification files in U.S., and EMDN in Europe as basic data to compare medical device products and derive medical devices with different management systems. As a result of comparing the definition and product classification systems of medical devices in Korea, the U.S. and Europe, medical device accessories, prosthetic limbs and aids among assistive devices for persons with disabilities, drugs, quasi-drugs and industrial products that are not managed by medical devices in Korea are managed as medical devices in the U.S. and Europe. This study aims to improve public health by securing systematic product safety management and essential performance under medical device regulations. Management within a single medical device system will increase the efficiency of licensing work of domestic medical device manufacturers and related organizations. It is also expected to help advance the system according to the international harmony of the item classification system and enhance smooth import and export competitiveness.

Polyamide 조리기구로부터 Ethylenediamine 및 Hexamethylenediamine의 이행에 관한 연구 (A Study on Migration of Ethylenediamine and Hexamethylenediamine from Polyamide Utensils)

  • 엄미옥;곽인신;윤예정;전대훈;최현철;김형일;성준현;박나영;김소희;이영자
    • 한국식품위생안전성학회지
    • /
    • 제25권1호
    • /
    • pp.36-42
    • /
    • 2010
  • 식품유사용매 중 EDA 및 HMDA 분석법을 확립하고, 국내유통 재질 조리기구 124건에 대하여 식품유사용매별 이행량을 조사하였다. EDA 및 HMDA를 ethyl chloroformate로 디우레탄 유도체화한 후 GC/FID로 정량 또는 GC/MS로 확인하였다. 확립된 분석방법은 EDA 및 HMDA 각각에 대하여 LOD $0.3\;{\mu}g/mL$$0.1\;{\mu}g/mL$이었으며, 상판계수($r^2$) 0.999이상의 직선성 및 식품유사용매별로 88% 이상의 회수율을 확인할 수 있었다. 확립된 정량분석방법을 적용하여 식품유사용매별 이행량을 조사한 결과, EDA는 식품유사용매로 물을 사용한 경우 2품목에서만 각각 $1.31\;{\mu}g/mL$$2.06\;{\mu}g/mL$ 수준으로 검출되었으며, 나머지는 모두 불검출이었다. HMDA는 식품유사용매로 20% 에탄올을 사용한 경우 3 품목에서 $0.27{\sim}0.93\;{\mu}g/mL$, n-헵탄을 사용한 경우 10 품목에서 $0.26{\sim}0.44\;{\mu}g/mL$으로 검출되었으며, 나머지는 모두 불검출이었다. 본 연구에서 확인된 이행량은 유럽연합의 EDA 및 HMDA 각각의 이행기준인 $12\;{\mu}g/mL$$2.4\;{\mu}g/mL$과 비교 시 매우 낮은 수준이었다.

대학교 교직원 및 그가족의 의료에 관한 연구 -이화 여자 대학교를 중심으로- (A Study on the Health Care of Ewha Womans University Staff, Faculty and Families)

  • 강지용
    • Journal of Preventive Medicine and Public Health
    • /
    • 제7권1호
    • /
    • pp.163-173
    • /
    • 1974
  • A study on the health care of Ewha Womans University staff, faculty and families was conducted during the period from March 1973 to August 1974 using designed questionaire. A total of 196 persons who were randomly sampled as 27.3% of the total staff and faculty 789 were studied. The response rates were 96.0%. The results and findings obtained from the study are summerized as follow. 1. The sex ratio of the members the faculty and the staff shows 83.2% and the singles are 37.2% of the total. Their mean family size being 4.6 persons per capita, each family has mean number of 2.3 childeren. 2. The median monthly income of a member of faculty amounts \114,000 and that of a staff \43,077. It amounts \79,333 when the median monthly income of both the members of the faculty and the staff are taken. Consequently, it amounts \91,727\ per family (Assumed mean). 3. 71.4% of the total hold the house of their own. A spouses of 59.4% of them are working for the additional income of the family. 4. Their health condition is rated fair, i. e. 92.3% of them enjoy good health. Out of total members faculty and the staff, 20.6% are cared by family physician. 36.2% of them feel that they are burdened by heavy medical expense. 5. 76.7% of them have affirmatively responded that they would purchase medical insurance policy when they were offered. It reaches 84.0% of the total who consider buying the policy for their dependents. 74.0% of them desire to purchase the policy for their spouse's parents. 6. The monthly prevalence rate reaches 17.0% and the hospital admission rate 4.7%.12.3% of them affirmatively responded that they had chronic diseas. The number of sick call per capita counts 0.2 per month and the hospital admission rate 0.05. 7. To examine the nature of their disease, the respiratory disease is rated to be the top and the gastro-intestinal disease comes to the next. As far as chronic disease is concerned, the gastro-intestinal disease is predominent. 8. As to their treatment, 65.4% of them get the physician's treatment and 17.0% treatment of drug purchasing and 7.7% prefer Chinesedrug. 6.6% of them gets no medical treatment at all. 9. The treatment ratio, including drug purchasing and other means, reaches 93.4%. 60.7% of them affirmatively responded that they did not or could not get physician's treatment at least once even though they thought they had to. It is disclosed that 25.4% of them are caused by economical reason. 10. Average medical expense per case amounts \7,116 and monthly medical expense per capita \1,345. Consequently, average monthly medical expense per family amounts \6,185. 11. The medical expense of a family is rated 7.7% of total earnings of the same period.

  • PDF

일부 종합병원의 건강검진 수검자들의 한약·양약 복합투여 (Combined utilization with herbal products and prescribed drugs: A result from health examinee-based national survey)

  • 박종구;최서영;고광욱;유준상;김태현;손동국;홍주희;송성은;김춘배
    • 보건행정학회지
    • /
    • 제16권1호
    • /
    • pp.1-16
    • /
    • 2006
  • Recently, there has been prevailing of the combined utilization (CU) with herbs and prescribed drugs in medical therapies in the world. But the information about frequency, efficacy and safety of this CU has not well known in Korea, yet. This study aimed to identify the status of CU by Koreans, and to inquire which side effects of CU represent to those people. A self-completed questionnaire survey was performed through each health examination center in twenty general hospitals and one oriental hospital. Of the initial 2,100 health examinees, 1,851 were participated in this survey, resulting in a response rate of 88.1%. The proportion of CD was 26.3%. The most commonly mentioned reason of CD was 'to promote general health and well-being' (17l persons, 35.5%). The main route of taking CD was self-purchase at drugstore or at herbs market, followed by the prescription of (oriental)physicians. 33.0% (151 persons) of those who took the CD rated it as effective. 93 respondents (19.8%) were experienced several adverse effects including nausea, fatigue, and dizziness. The growing simultaneous use of herbal products and pharmaceutical drugs by Korean consumers may be continuously increased the risk of herb-drug interactions. The medical professionals should be provided with comprehensive and up-to-date information about potential benefits and risks of herbs and prescribed drugs. In the future studies it may be recommended to deal common cold, health promotion, indigestion, headache, and hypertension for the effect and safety of the CD by well-organized prospective study design.

한국형 외래환자분류체계의 개선과 평가: 복수시술 및 항암제 진료와 내과적 방문지표를 중심으로 (Refinement and Evaluation of Korean Outpatient Groups for Visits with Multiple Procedures and Chemotherapy, and Medical Visit Indicators)

  • 박하영;강길원;윤성로;박은주;최성운;유승학;양은주
    • 보건행정학회지
    • /
    • 제25권3호
    • /
    • pp.185-196
    • /
    • 2015
  • Background: Issues concerning with the classification accuracy of Korean Outpatient Groups (KOPGs) have been raised by providers and researchers. The KOPG is an outpatient classification system used to measure casemix of outpatient visits and to adjust provider risk in charges by the Health Insurance Review & Assessment Service in managing insurance payments. The objective of this study were to refine KOPGs to improve the classification accuracy and to evaluate the refinement. Methods: We refined the rules used to classify visits with multiple procedures, newly defined chemotherapy drug groups, and modified the medical visit indicators through reviews of other classification systems, data analyses, and consultations with experts. We assessed the improvement by measuring % of variation in case charges reduced by KOPGs and the refined system, Enhanced KOPGs (EKOPGs). We used claims data submitted by providers to the HIRA during the year 2012 in both refinement and evaluation. Results: EKOPGs explicitly allowed additional payments for multiple procedures with exceptions of packaging of routine ancillary services and consolidation of related significant procedures, and discounts ranging from 30% to 70% were defined in additional payments. Thirteen chemotherapy drug KOPGs were added and medical visit indicators were streamlined to include codes for consultation fees for outpatient visits. The % of variance reduction achieved by EKOPGs was 48% for all patients whereas the figure was 40% for KOPGs, and the improvement was larger in data from tertiary and general hospitals than in data from clinics. Conclusion: A significant improvement in the performance of the KOPG was achieved by refining payments for visits with multiple procedures, defining groups for visits with chemotherapy, and revising medical visit indicators.

우리나라 학교보건교육의 현황과 과제 (Future Directions of School Health Education Policy and Practice in Korea)

  • 김혜경;고승덕
    • 보건교육건강증진학회지
    • /
    • 제24권4호
    • /
    • pp.219-230
    • /
    • 2007
  • The purpose of this study was to identify the current problems of school health education policies and practices in Korea, and to establish the strategies to improve the effectiveness and efficiency of school health education program. The severity of adolescents's health problems including obesity, smoking, drug abuse, teen pregnancy, etc has been increased recently and coping strategies to deal with these problems became urgent. The role of school as a key setting for health education should be empathized. However, there were limitations for the effectiveness of school health education in Korea because of the lack of recognition about the importance, guiding principles of the school health education by the school health related law, life skill-focused curriculum, capacity of teachers for health education, and linkage between school and community. In order to improve the effectiveness of school health education, establishment of infrastructure, national and local health education standard, and operating principles for the school health education program should be provided. Life skill-focused health education curriculum should be developed for the effective health education. Teacher training and education also should be the essential component of school health education program. For the improvement of efficiency in school health education practices, cooperation with family and community support system would be necessary.

A Patent Analysis for the Strategic Landscape of Firms: Cancer Metabolism

  • Kim, Keun-hwan;Kim, Kang-hoe;Lee, Ho-shin;Shim, We
    • Asian Journal of Innovation and Policy
    • /
    • 제5권3호
    • /
    • pp.293-314
    • /
    • 2016
  • Patent information as a proxy measure of technological capability has been utilized to establish technological strategies of firms. It is important to monitor what competitors' plans for direction on research and development in the initial stage of new industry. Cancer metabolism has been considered as a beacon of hope for cancer research because it is anticipated that the research field will play a central role in developing effective cancer therapies. There is little attention given to understanding the status quo of organizational configurations. By utilizing network analysis, six sub-groups of cancer metabolism were categorized and the relationship between an individual field and participants were analyzed based on cluster and entire network-level. Although the largest drug and biotech companies tried to take an initiative across the whole fields, the differences in technological capabilities between them was discovered. This paper attempts to improve the validity of the suggested procedure and is significant in that it looks at the entire structure of cancer metabolism research from a strategic perspective for the first time.

포괄수가제 당연적용 후 의약품 사용현황 분석 (Analysis of Drug Utilization after the Mandatory Application of the DRG Payment System in Korea)

  • 강희정;김지만;임재영;이상규;신의철
    • 한국병원경영학회지
    • /
    • 제23권2호
    • /
    • pp.18-27
    • /
    • 2018
  • Purposes: This study aims to investigate the policy effect of mandatory application of DRG for 7 disease groups in general and tertiary hospitals. Methodology: As DRG was fully implemented in July 2013, this study compares two periods before and after the change(from July 2012 to June 2013, and from July 2013 to June 2014). The benefit claim data of the National Health Insurance Service was used for the comparison. Target patients were those who visited general or tertiary hospitals between July 2012 to June 2014. For pharmaceutical consumption, Interrupted Time Series (ITS) analysis was used to see the effect of DRG mandatory application. Findings: The number of drugs prescribed per patient and pharmaceutical expenditure both showed significant reduction compared to before the DRG implementation. Practical Implications: This study used 2 sets of 1 year period data from before and after the full implementation of DRG to analyze pharmaceutical consumption. When the comparison data accumulates further, it would be possible to conduct more diverse analysis to assess policy effect and to provide way forward for the future.